Terms: = Head and neck cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Treatment
106 results:
1. Nomograms based on the lymphocyte-albumin-neutrophil ratio (LANR) for predicting the prognosis of nasopharyngeal carcinoma patients after definitive radiotherapy.
Zhang S; Chen Z; Ling J; Feng Y; Xie Y; Liu X; Hu C; Hou T
Sci Rep; 2024 Mar; 14(1):5388. PubMed ID: 38443675
[TBL] [Abstract] [Full Text] [Related]
2. A meta-analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapy.
Jang JY; Kim K; Chen MF; Akimoto T; Wang MLC; Kim MJ; Kim K; Lee TH; Yoo GS; Park HC
Cancer Med; 2024 Feb; 13(3):e7023. PubMed ID: 38396380
[TBL] [Abstract] [Full Text] [Related]
3. Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
Serafini MS; Cavalieri S; Licitra L; Pistore F; Lenoci D; Canevari S; Airoldi M; Cossu Rocca M; Strojan P; Kuhar CG; Merlano M; Perrone F; Vingiani A; Denaro N; Perri F; Argiris A; Gurizzan C; Ghi MG; Cassano A; Allegrini G; Bossi P; De Cecco L
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38290766
[TBL] [Abstract] [Full Text] [Related]
4. Serum cell division control 42 reflects treatment response and survival profiles in recurrent or metastatic oral squamous cell carcinoma patients who receive programmed death-1 inhibitors.
Chen Y; Chen Y; Liu W
Int Immunopharmacol; 2024 Mar; 129():111547. PubMed ID: 38290205
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptional Inflammatory Signature in Healthy Donors and Different Radiotherapy cancer Patients.
O'Brien G; Kamuda M; Cruz-Garcia L; Polozova M; Tichy A; Markova M; Sirak I; Zahradnicek O; Widłak P; Ponge L; Polanska J; Badie C
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256152
[TBL] [Abstract] [Full Text] [Related]
6. Molecular Profiling for Bethesda III to VI Nodules: Results of a Multicenter International Retrospective Study.
Morand GB; Tessler I; Noik M; Krasner J; Yamin T; Pusztaszeri MP; Avior G; Payne RJ
Endocr Pract; 2024 Apr; 30(4):319-326. PubMed ID: 38184241
[TBL] [Abstract] [Full Text] [Related]
7. The Optimal treatment Strategy for Postoperative Anastomotic Leakage After Esophagectomy: a Comparative Analysis Between Endoscopic Vacuum Therapy and Conventional treatment.
Lee J; Jeon JH; Yoon SH; Shih BC; Jung W; Hwang Y; Cho S; Kim K; Jheon S
J Gastrointest Surg; 2023 Dec; 27(12):2899-2906. PubMed ID: 38040922
[TBL] [Abstract] [Full Text] [Related]
8. [Analysis of 9 cases of pediatric-type follicular lymphoma].
Li GP; Zhang D; Wang YQ; Li ZY; Yuan FF; Li MH; Wang L; Du JW; Zhang LN; Li YF; Wei XD; Fu YW
Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1129-1132. PubMed ID: 38018051
[No Abstract] [Full Text] [Related]
9. Preliminary Results of a Double-Blind Randomized Controlled Trial Evaluating the Cardiometabolic Effects of Levothyroxine and Liothyronine Compared to Levothyroxine with Placebo in Athyreotic Low-Risk Thyroid cancer Patients.
Biondi B; Pucci M; Pontieri G; Formisano P; Esposito R
Thyroid; 2023 Dec; 33(12):1402-1413. PubMed ID: 37725587
[No Abstract] [Full Text] [Related]
10. Network-Based Method to Investigate the Promoted Cell Apoptosis Mechanisms of Oridonin in OSCC through the RNA-Transcriptome.
Wu G; Guo Y; Liu Y; Cai X; Deng T; Pei T; Huang L; Chen K; Pan X
J Immunol Res; 2023; 2023():5293677. PubMed ID: 36969496
[TBL] [Abstract] [Full Text] [Related]
11. Feasibility analysis of combined surgery for esophageal cancer.
Wang Z; Sun S; Li K; Huang C; Liu X; Zhang G; Li X
World J Surg Oncol; 2023 Feb; 21(1):41. PubMed ID: 36765428
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in Lymph-Node-Stage III nasopharyngeal carcinoma based on propensity score-matching.
Liu ZC; Zeng KH; Gu ZB; Chen RP; Luo YJ; Tang LQ; Zhu KB; Liu Y; Sun XS; Zeng L
Radiother Oncol; 2023 Jan; 178():109421. PubMed ID: 36410548
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy of first-line systemic treatment regimens for recurrent/metastatic head and neck squamous cell carcinoma: a network meta-analysis.
Yu X; Su X; Fang L; Zhang H; Chen X; Pu Y; Liu H; Guo R
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1391-1401. PubMed ID: 36181527
[TBL] [Abstract] [Full Text] [Related]
14. Demystifying the Functional Role of Nuclear Receptors in Esophageal cancer.
Jayaprakash S; Hegde M; Girisa S; Alqahtani MS; Abbas M; Lee EHC; Yap KC; Sethi G; Kumar AP; Kunnumakkara AB
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142861
[TBL] [Abstract] [Full Text] [Related]
15. Endoscopic versus Nonendoscopic Surgery for Resection of Craniopharyngiomas.
Abiri A; Roman KM; Latif K; Goshtasbi K; Torabi SJ; Lehrich BM; Mohyeldin A; Hsu FPK; Kuan EC
World Neurosurg; 2022 Nov; 167():e629-e638. PubMed ID: 36041722
[TBL] [Abstract] [Full Text] [Related]
16. The course of swallowing problems in the first 2 years after diagnosis of head and neck cancer.
Vermaire JA; Raaijmakers CPJ; Monninkhof EM; Leemans CR; Baatenburg de Jong RJ; Takes RP; Leeuw IMV; Jansen F; Langendijk JA; Terhaard CHJ; Speksnijder CM
Support Care Cancer; 2022 Nov; 30(11):9527-9538. PubMed ID: 36040669
[TBL] [Abstract] [Full Text] [Related]
17. MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma.
Pei W; Wang C; Liao H; Chen X; Wei Y; Huang X; Liang X; Bao H; Su D; Jin G
BMC Cancer; 2022 Jul; 22(1):739. PubMed ID: 35794590
[TBL] [Abstract] [Full Text] [Related]
18. Association Between PD-L1 and Histatin1, 3 Expression in Advanced head and neck Squamous Cell Carcinoma.
Wongpanuwich W; Yodsanga S; Chaisuparat R; Amornphimoltham P
Anticancer Res; 2022 May; 42(5):2689-2699. PubMed ID: 35489730
[TBL] [Abstract] [Full Text] [Related]
19. Demographic, endoscopic and histological profile of esophageal cancer at the Gastroenterology Department of Maputo Central Hospital from January 2016 to December 2018.
Ismail M; Mondlane L; Loforte M; Dimande L; Machatine S; Carrilho C; Sacarlal J
Pan Afr Med J; 2022; 41():100. PubMed ID: 35465369
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of a Remote Monitoring Program for Symptoms Among Adults With cancer Receiving Antineoplastic Therapy.
Daly B; Nicholas K; Flynn J; Silva N; Panageas K; Mao JJ; Gazit L; Gorenshteyn D; Sokolowski S; Newman T; Perry C; Wagner I; Zervoudakis A; Salvaggio R; Holland J; Chiu YO; Kuperman GJ; Simon BA; Reidy-Lagunes DL; Perchick W
JAMA Netw Open; 2022 Mar; 5(3):e221078. PubMed ID: 35244701
[TBL] [Abstract] [Full Text] [Related]
[Next]
